So in your opinion, Plotinus, what is the primary
Post# of 157632
Seems like deja vu with CRC.
Is it just the amount of paperwork and hassle the MD incurs with enrolling a patient in a study? Does he put himself at legal risk for recommending a patient for study inclusion?
And is there anything that Cytodyn could do to encourage more participation? Meetings, doctor/patient seminars, have you seen other companies do things like this?

